Navigation Links
Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
Date:5/20/2008

Lawson, M.D., Emory University School of Medicine. "Identifying novel therapies like elesclomol represent the future of treating this hard-to-treat disease."

Data for patients on the elesclomol and paclitaxel arm who had one prior chemotherapy showed a trend toward results similar to patients who had received no prior chemotherapy; however these data were not statistically significant. Specifically, after receiving one prior chemotherapy, the median PFS was 2.8 months for patients receiving elesclomol and paclitaxel (n=29) versus 1.8 months for patients on paclitaxel alone (n=20; p=0.552), and OS was 9.0 months for patients on elesclomol and paclitaxel versus 7.8 months for patients on paclitaxel alone.(1)

Regardless of prior chemotherapy, the most common adverse events in the elesclomol plus paclitaxel group included fatigue, alopecia, constipation, nausea, hypoaesthesia, arthralgia, insomnia, diarrhea and anemia. The most serious adverse events (Grade 3 or higher) for the combination arm were similar to those seen in the paclitaxel-only arm and included neutropenia, back pain, fatigue and neuropathy.(1)

About Elesclomol

Elesclomol is a novel, injectable, investigational drug candidate that triggers apoptosis (programmed cell death) in cancer cells. Cancer cells operate at high levels of reactive oxygen species, or oxidative stress. Elesclomol is believed to act by increasing the level of oxidative stress in cancer cells even further, beyond sustainable levels, inducing apoptosis. This mechanism of action, called oxidative stress induction, represents a novel way of selectively targeting and killing cancer cells.

Elesclomol is being developed under a global collaboration agreement between Synta Pharmaceuticals and GlaxoSmithKline.

Ongoing Clinical Trials

GlaxoSmithKline and Synta Pharmaceuticals are currently studying elesclomol in a global, pivotal Phase III trial called SYMMETRY(SM). The SYMMETRY study is being con
'/>"/>

SOURCE GlaxoSmithKline; Synta Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
2. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
3. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
4. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
5. Amikacin Inhale Shows Promising Results in Phase II Study
6. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
7. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
8. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
9. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
10. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
11. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... BAUDETTE, Minn. , March 31, 2015 ... announced the launch of Propafenone Hydrochloride 150mg, 225mg and ... of various arrhythmias. The overall US market for Propafenone ... in 2014, per IMS Health. Arthur ... "We are pleased to announce the launch of our ...
(Date:3/31/2015)... , March 31, 2015  Oxis International, Inc. (OXIS) ... development and commercialization, announced today Oxis CEO Tony ... of Oxis common shares on the Euronext exchange. Oxis ... the symbol OXIS.   Oxis Chairman and ... to move forward with its strategies launched in 2014 ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and ... the addition of the "North American Laboratory ... Information System), by Type (Clinical Pathology Laboratory Information ... to 2019" report to their offering. ... is estimated to grow at a CAGR of ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Oxis International Inc. Announces Request for Euronext Trading Suspension 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 3
... Highlights ... generation of medical image management products and services. ... technologists. Harris Corporation (NYSE: ... company, and Johns Hopkins Medicine today announced a joint ...
... American Regent is conducting a voluntary nationwide recall of the following products:Con c entate dSodi ... mL Sing l e Do s e V i al ... c entatedS o di u mCh l or i d eInjection ... c yBulka c ka g e N DC# 0 5 ...
Cached Medicine Technology:Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 2American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 3American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 4American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 5
(Date:3/31/2015)... Clara, CA (PRWEB) March 31, 2015 ... (IPD), has introduced a wire-bondable silicon ESD diode chip targeted ... of bare-die diode offerings, these Zeners are ideal for protecting ... ESD2117 diode can handle pulses of up to ... level 4 of the IEC 61000-4-2 standard. These diodes ...
(Date:3/31/2015)... 31, 2015 Clinovo, a leading ... Membership Program , the premiere voice of Northern ... life science companies. , BayBio brings together ... most innovative and productive life science cluster, helping ... of humanity’s most pressing challenges. , “We ...
(Date:3/31/2015)... At Summit Breast Care, their passion is to ... and caring manner. , Summit Breast Care has achieved national ... breast cancer. They treat thousands of patients annually, not ... world. Their doctors continue to be recognized as ‘Top ... Summit Breast Care were planted in the mind and spirit ...
(Date:3/31/2015)... Beckman Coulter is sponsoring a new ... Particulate Matter in Therapeutic Protein Injections”,” an educational session that ... counting particles in liquids, with a focus on the challenges ... to attend and will be broadcast live April 8, 2015 ... test for protein-based materials, known as USP 787 , ...
(Date:3/31/2015)... BESLER Consulting today announced the ... of an Independent Cost Report Review.” , The ... role in the determination of Medicare reimbursement to ... and review, this report can assist management in ... This white paper discusses:,     The ...
Breaking Medicine News(10 mins):Health News:OnChip Introduces Low Voltage Diodes for High-Brightness LED Protection 2Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3
... India's leading vaccine manufacturer Serum Institute of India has manufactured ... vaccines // . ,The vaccine is called Td-Vac ... adolescents and adults. The new vaccine will replace the existing ... ,Td-Vac is priced at Rs 7.50 whereas the TT ...
... has given health the status of industry. The positive ... all facilities provided under the industrial policy. Nursing homes ... support. ,The government move is expected to ... sector in state, where half the population lives below ...
... Israeli scientists have developed a test that can detect the ... led by Arieh Yaari of Soroka University Medical Centre // ... patients, people without kidney functions whose blood must be passed ... portal SciDev Net. ,Such patients have a high incidence ...
... soaps or serials give a false picture about coma survival ... data of sufferings felt // by coma patients and ... television soaps is not true as the study show that ... for instance, compared with 50% upwards in real life. ...
... fear that if the deadly bird flu hits the country then ... // to the H5N1 virus. The bird flu or the avian ... appeared in parts of Europe including Ukraine. ,Around ... the virus. However, experts fear that if it mutates to a ...
... Researchers from the University of Pennsylvania have obtained valuable ... using a technique // called functional magnetic resonance imaging. ... the brain that are active during an event are ... ,"This study shows that, as you search ...
Cached Medicine News:Health News:Magnetic Resonance Imaging Can Now Be Used For Mind Reading 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: